MIR-190B-5P EXPRESSION IS A HIGHLY RELIABLE DISCRIMINATOR BETWEEN ER-POSITIVE AND ER-NEGATIVE BREAST CANCER

被引:0
|
作者
Iyevleva, A. [1 ]
Bizin, I. [1 ]
Sokolenko, A. [1 ]
Venina, A. [1 ]
Anisimova, E. [2 ]
Holmatov, M. [1 ]
Romanko, A. [1 ]
Stepanov, I. [1 ]
Togo, A. [1 ]
Imyanitov, E. [1 ]
机构
[1] NN Petrov Inst Oncol, St Petersburg, Russia
[2] Leningrad Reg Canc Hosp, St Petersburg, Russia
基金
俄罗斯科学基金会;
关键词
D O I
10.1136/ijgc-2019-ESGO.271
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP209
引用
收藏
页码:A181 / A181
页数:1
相关论文
共 50 条
  • [1] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    Jordan, VC
    [J]. BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S4 - S4
  • [2] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    VC Jordan
    [J]. Breast Cancer Research, 7
  • [3] AgNOR analysis of ER-positive and ER-negative cells in breast cancer.
    Guski, H
    Winzer, KJ
    Hufnagl, P
    Gunther, L
    [J]. EUROPEAN JOURNAL OF HISTOCHEMISTRY, 1996, 40 (04): : 341 - 341
  • [4] AgNOR analysis of ER-positive and ER-negative tumor cells in breast cancer
    Guski, E
    Winzer, KJ
    Hufnagl, P
    Günther, L
    Kaufmann, O
    [J]. PROCEEDINGS OF THE GERMAN SOCIETY FOR PATHOLOGY 82ND MEETING - 1998: SOFT TISSUE TUMORS, 1998, : 470 - 470
  • [5] Oxysterol signalling is retained in ER-negative and supressed in ER-positive breast cancer
    Hutchinson, Samantha
    Battaglia, Sebastiano
    Roberg-Larsen, Hanne
    Lianto, Priscilia
    Hughes, Thomas
    Thorne, James
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 2020, 79 (OCE2) : E142 - E142
  • [6] Interleukin-8 in progression of ER-positive and ER-negative breast cancer patients
    Todorovic-Rakovic, N.
    Milovanovic, J.
    Abu Rabi, Z.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 57 : S115 - S115
  • [7] Genetic Copy Number Differences Between ER-positive and ER-negative Human Breast Carcinoma
    Fang, M.
    Toher, J.
    Morgan, M.
    Davison, J.
    Tannenbaum, S.
    Claffey, K.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 666 - 666
  • [8] Cell signaling events differentiate ER-negative subtypes from ER-positive breast cancer
    Maria J. Worsham
    Dhanajay Chitale
    Kang Mei Chen
    Indrani Datta
    George Divine
    [J]. Medical Oncology, 2015, 32
  • [9] Cell signaling events differentiate ER-negative subtypes from ER-positive breast cancer
    Worsham, Maria J.
    Chitale, Dhanajay
    Chen, Kang Mei
    Datta, Indrani
    Divine, George
    [J]. MEDICAL ONCOLOGY, 2015, 32 (05)
  • [10] Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer
    Witton, CJ
    Hawe, SJK
    Cooke, TG
    Bartlett, JMS
    [J]. HISTOPATHOLOGY, 2004, 45 (01) : 47 - 54